Market Overview:
Ultrasound contrast agents are used to improve the visibility of internal body structures during medical imaging procedures. The global ultrasound contrast agents market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into microbubbles contrast agents and liquid fluorocarbon nano emulsion. Microbubbles contrast agents are further sub-segmented into gas-filled microbubbles and lipid-shelled microbubbles. On the basis of application, the market is segmented into hospitals, clinics, and other applications. Geographically, the global ultrasound contrast agents market is divided into North America, Latin America, Europe Asia Pacific (APAC), and Middle East & Africa (MEA). The global ultrasound contrast agents market was valued at US$ 1.5 Bn in 2017 and is projected to reach US$ 3 Bn by 2030 at a CAGR of 9%. The growth in this market can be attributed to factors such as rising prevalence of chronic diseases; increasing number of diagnostic procedures; technological advancements in medical imaging devices; growing demand for minimally invasive surgeries; rising awareness about early diagnosis & treatment options for various diseases among patients & healthcare professionals;and increasing investments by key players in R&D activities for new product launches. However,.
Product Definition:
Ultrasound contrast agents are small bubbles filled with gas or air. They are used to improve the appearance of internal organs and tissues on ultrasound images. The importance of ultrasound contrast agents is that they can help doctors see abnormalities and tumors more clearly.
Microbubbles Contrast Agents:
Microbubbles contrast agents are small bubble contrast agents that are used in ultrasound imaging. They help in enhancing the image quality by providing enhanced spatial resolution and improved detection sensitivity. The microbubble contrast agent market is expected to grow at a significant rate owing to its increasing use in ultrasound imaging as it helps detect blood clots, kidney stones, gallstones and pancreatic tumors with greater accuracy.
Liquid Fluorocarbon Nano Emulsion:
Nano-emulsions of fluorocarbon and a non-fluorocarbon are prepared by using micelles as the basic building blocks. The resulting nano-emulsion has an average particle size of around 100 nm and is stable in nature. Such nanoparticles are called liquid fluorocarbon nano emulsions (LFNE).
The major application of such LFNE is to be used as ultrasound contrast agents for imaging purposes.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and other. The other applications include MRA/CAT/CT imaging centers and emergency services. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a large number of applications such as musculoskeletal, cardiology & cardiovascular, nuclear medicine and pain management.
The growing prevalence of chronic diseases such as cancer along with an increase in the geriatric population group is expected to drive demand for ultrasound contrast agents over the forecast period. Furthermore, increasing investments by governments for developing advanced healthcare facilities along with rising awareness regarding these agents are further anticipated to boost growth over the coming years. Increasing investment by companies for R&D activities pertaining to new product development is also likely to contribute toward market growth during this period (2017-2030).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure and high adoption rate for advanced technologies are some factors responsible for its large share. Moreover, increasing number of clinical studies pertaining to the use of ultrasound contrast agents is expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rising demand from developing countries such as China and India. In addition, favorable government initiatives aimed at improving healthcare facilities in emerging economies are likely to contribute toward regional expansion.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) and other medical conditions that can be diagnosed with the help of ultrasound contrast agents
- Growing demand for minimally invasive diagnostic procedures
- Technological advancements in ultrasound contrast agent technology
- Rising number of clinical studies on the efficacy and safety of ultrasound contrast agents
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Ultrasound Contrast Agents Market Research Report
By Type
Microbubbles Contrast Agents, Liquid Fluorocarbon Nano Emulsion
By Application
Hospitals, Clinics, Other
By Companies
Lantheus Medical Imaging, Bracco SpA, GE Healthcare, Daiichi Sankyo Company, Bayer, Guerbet Group, Hengrui Medicine, BeiLu Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
189
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Ultrasound Contrast Agents Market Report Segments:
The global Ultrasound Contrast Agents market is segmented on the basis of:
Types
Microbubbles Contrast Agents, Liquid Fluorocarbon Nano Emulsion
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lantheus Medical Imaging
- Bracco SpA
- GE Healthcare
- Daiichi Sankyo Company
- Bayer
- Guerbet Group
- Hengrui Medicine
- BeiLu Pharmaceutical
Highlights of The Ultrasound Contrast Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microbubbles Contrast Agents
- Liquid Fluorocarbon Nano Emulsion
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ultrasound Contrast Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ultrasound contrast agents are substances that help doctors see structures in the body more clearly during an ultrasound exam. Contrast agents can be used to highlight blood vessels, tumors, and other abnormalities.
Some of the major players in the ultrasound contrast agents market are Lantheus Medical Imaging, Bracco SpA, GE Healthcare, Daiichi Sankyo Company, Bayer, Guerbet Group, Hengrui Medicine, BeiLu Pharmaceutical.
The ultrasound contrast agents market is expected to grow at a compound annual growth rate of 9%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ultrasound Contrast Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ultrasound Contrast Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ultrasound Contrast Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ultrasound Contrast Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ultrasound Contrast Agents Market Size & Forecast, 2018-2028
4.5.1 Ultrasound Contrast Agents Market Size and Y-o-Y Growth
4.5.2 Ultrasound Contrast Agents Market Absolute $ Opportunity
Chapter 5 Global Ultrasound Contrast Agents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ultrasound Contrast Agents Market Size Forecast by Type
5.2.1 Microbubbles Contrast Agents
5.2.2 Liquid Fluorocarbon Nano Emulsion
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ultrasound Contrast Agents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ultrasound Contrast Agents Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ultrasound Contrast Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ultrasound Contrast Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ultrasound Contrast Agents Analysis and Forecast
9.1 Introduction
9.2 North America Ultrasound Contrast Agents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ultrasound Contrast Agents Market Size Forecast by Type
9.6.1 Microbubbles Contrast Agents
9.6.2 Liquid Fluorocarbon Nano Emulsion
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ultrasound Contrast Agents Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ultrasound Contrast Agents Analysis and Forecast
10.1 Introduction
10.2 Europe Ultrasound Contrast Agents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ultrasound Contrast Agents Market Size Forecast by Type
10.6.1 Microbubbles Contrast Agents
10.6.2 Liquid Fluorocarbon Nano Emulsion
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ultrasound Contrast Agents Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ultrasound Contrast Agents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ultrasound Contrast Agents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ultrasound Contrast Agents Market Size Forecast by Type
11.6.1 Microbubbles Contrast Agents
11.6.2 Liquid Fluorocarbon Nano Emulsion
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ultrasound Contrast Agents Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ultrasound Contrast Agents Analysis and Forecast
12.1 Introduction
12.2 Latin America Ultrasound Contrast Agents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ultrasound Contrast Agents Market Size Forecast by Type
12.6.1 Microbubbles Contrast Agents
12.6.2 Liquid Fluorocarbon Nano Emulsion
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ultrasound Contrast Agents Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ultrasound Contrast Agents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ultrasound Contrast Agents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ultrasound Contrast Agents Market Size Forecast by Type
13.6.1 Microbubbles Contrast Agents
13.6.2 Liquid Fluorocarbon Nano Emulsion
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ultrasound Contrast Agents Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ultrasound Contrast Agents Market: Competitive Dashboard
14.2 Global Ultrasound Contrast Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lantheus Medical Imaging
14.3.2 Bracco SpA
14.3.3 GE Healthcare
14.3.4 Daiichi Sankyo Company
14.3.5 Bayer
14.3.6 Guerbet Group
14.3.7 Hengrui Medicine
14.3.8 BeiLu Pharmaceutical
